Merck on Enhancing Trial Participation, Relevance, and Impact through Patient and Community Engagement

In this session from the March 2025 Patients as Partners in Clinical Research conference, Merck presented how they advanced patient and community engagement through targeted initiatives designed to improve trial participation, relevance, and long-term impact. The key topics addressed included:

  • Identifying and addressing patient and community needs
  • Strategies for earning trust and fostering sustained engagement
  • Key collaborations and partnerships driving meaningful change
  • Approaches to developing patient-centered endpoints and outcomes
  • Methods for effectively communicating and disseminating trial results

For more information, go to PatientsAsPartnersconference.com


Speakers
Luther Clark, MD
Executive Director, Patient Innovation & Engagement, V&I Global Medical and Scientific Affairs
Merck
This content was created by The Conference Forum staff. The Fierce editorial team did not contribute to this work.